A medical invention changing the life for diabetic patients globally.
LeucoPatch is an easy to use medical device and process to provide active cell therapy. LeucoPatch is developed by Reapplix, a regenerative medical company focused on helping patients with chronic and hard to heal wounds. A privately held company, Reapplix is backed by Seed Capital, Novo Seeds and The Danish Growth Fund.
“LeucoPatch solves a significant problem among diabetics. It is simple to use and it utilizes the body’s own biology. The product reflects thorough research and has very significant knowledge built into it. Therefore, it wins the Innovation Award.”
– ‘The Engineer’ Product Prize 2014, Innovation category